Pages that link to "Q43858707"
Jump to navigation
Jump to search
The following pages link to Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine (Q43858707):
Displaying 50 items.
- Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly (Q21560857) (← links)
- Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin (Q21562628) (← links)
- Neuraminidase inhibitors for preventing and treating influenza in adults and children (Q24197463) (← links)
- Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China (Q24633856) (← links)
- Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study (Q24643173) (← links)
- Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population (Q24655857) (← links)
- Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic? (Q26783481) (← links)
- Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore (Q27331905) (← links)
- Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates (Q27348520) (← links)
- Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus (Q27660330) (← links)
- Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome (Q28071857) (← links)
- Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets (Q28474889) (← links)
- Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico (Q28729170) (← links)
- Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine (Q28744349) (← links)
- Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice (Q28744391) (← links)
- Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice (Q28748950) (← links)
- Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection (Q28749544) (← links)
- The shifting demographic landscape of influenza (Q28750491) (← links)
- Optimal pandemic influenza vaccine allocation strategies for the Canadian population (Q28752312) (← links)
- Epitope specific T-cell responses against influenza A in a healthy population. (Q30202358) (← links)
- The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment (Q30205724) (← links)
- Large-scale analysis of B-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies (Q30217235) (← links)
- The effectiveness of U.S. public health surveillance systems for situational awareness during the 2009 H1N1 pandemic: a retrospective analysis (Q30224471) (← links)
- Two years after pandemic influenza A/2009/H1N1: what have we learned? (Q30224656) (← links)
- New variants and age shift to high fatality groups contribute to severe successive waves in the 2009 influenza pandemic in Taiwan (Q30224859) (← links)
- The elusive definition of pandemic influenza (Q30226494) (← links)
- Seroprevalence to Influenza A(H1N1) 2009 Virus—Where Are We? (Q30226546) (← links)
- The 2009 influenza A (H1N1) pandemic: what have we learned in the past 6 months. (Q30227033) (← links)
- What have we learned from the novel influenza A (H1N1) pandemic in 2009 for strengthening pandemic influenza preparedness? (Q30227243) (← links)
- Swine-origin H1N1 influenza A virus and dental practice: a critical review (Q30227348) (← links)
- Influenza pandemic preparedness and severity assessment of pandemic (H1N1) 2009 in South-east Asia (Q30227371) (← links)
- The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness (Q30227681) (← links)
- Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trial. (Q30352104) (← links)
- Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection (Q30352501) (← links)
- Serological response of patients with influenza A (H1N1) pdm09-associated pneumonia: an observational study. (Q30356492) (← links)
- Detecting and diagnosing hotspots for the enhanced management of hospital Emergency Departments in Queensland, Australia. (Q30356512) (← links)
- Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice. (Q30357331) (← links)
- The pandemic influenza A (H1N1) 2009 vaccine does not increase the mortality rate of idiopathic interstitial pneumonia: a matched case-control study. (Q30359671) (← links)
- Substantial Morbidity and Mortality Associated with Pandemic A/H1N1 Influenza in Mexico, Winter 2013-2014: Gradual Age Shift and Severity (Q30361506) (← links)
- Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic (Q30363471) (← links)
- Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations (Q30369098) (← links)
- Amino acid substitutions in hemagglutinin of the 2009 pandemic influenza A(H1N1) viruses that might affect the viral antigenicity (Q30370125) (← links)
- Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses. (Q30370987) (← links)
- Phase 1 study of pandemic H1 DNA vaccine in healthy adults (Q30373824) (← links)
- Early vaccine availability represents an important public health advance for the control of pandemic influenza. (Q30374481) (← links)
- Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns. (Q30374546) (← links)
- Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine (Q30375872) (← links)
- Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic. (Q30380254) (← links)
- Modelling the progression of pandemic influenza A (H1N1) in Vietnam and the opportunities for reassortment with other influenza viruses (Q30380376) (← links)
- Prospects for control of emerging infectious diseases with plasmid DNA vaccines. (Q30380454) (← links)